Sage Journals: Discover world-class research

Abstract

Among malignant lymphoproliferative disorders, an association with lymph node infarction appeared most frequently in diffuse large B-cell lymphoma (DLBCL), followed by that in follicular lymphoma (FL). However, little is known about antigen preservation in the infarcted lymphoid tissue. FLs eventually transformed to diffuse lymphomas, comprising a significant proportion of DLBCLs. To examine the antigen preservation of the follicular center cell markers in the infarcted lymphoma, we studied 7 DLBCLs and 4 FLs diagnosed concurrently with or following lymph node infarction. Sections of viable and infarcted tissue were immunostained in parallel by using a panel of antibodies effective in routinely processed, wax-embedded tissue. The panel included L26 (CD20), 56C6 (CD10), 124 (BCL-2), and polyclonal BCL-6 antibody. The present study indicated that CD20 (91%) and CD10 (80%) antigen appear to be well preserved even in infarcted lymphoma tissues and provide useful information regarding the infarcted material. However, BCL-2 (40%) and BCL-6 (0%) antigens were of little or no value in the infarcted lymphoid tissues.

Keywords

lymph node infarction malignant lymphoma follicular lymphoma diffuse large B-cell lymphoma immunohistochemistry

Get full access to this article

View all access options for this article.

References

Davies JD , Stansfeld AG . Spontaneous infarction of superficial lymph nodes. J Clin Pathol 25:689-696 1972

Clearry KR , Osborne BM , Butler JJ . Lymph node infarction foreshadowing malignant lymphoma. Am J Surg Pathol 6:435-442 1982

Maurer R , Schmid U , Davies JD , Mahy J , Stansfeld AG , Lukes RJ . Lymph node infarction and malignant lymphoma: A multicentre survey of European, English and American cases. Histopathology 10:571-588 1986

Ioachim HL , Ratech H . Ioachim’s lymph node pathology, 3rd ed. Lippincott Williams & Wilkins, Philadelphia, pp. 271-273, 2002

Frizzera G , Wu CD , Inghirami G . The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. Am J Clin Pathol 111(Suppl 1):13-39, 1999

Norton AJ , Ramsay AD , Isaacson PG . Antigen preservation in infarcted lymphoid tissue: A novel approach to the infarcted lymph node using monoclonal antibodies effective in routinely processed tissues. Am J Surg Pathol 12:759-767 1988

Strauchen JA , Miller LK . Lymph node infarction. An immunohistochemical study of 11 cases. Arch Pathol Lab Med 127:60-63 2003

Dogan A , Bagdi E , Munson P , Isaacson PG . CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas. Am J Surg Pathol 24:846-852 2000

King BE , Chen C , Locker J , Kant J , Okuyama K , Falini B , Swerdlow SH . Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas. Mod Pathol 13:1219-1231 2000

10.

Ree HJ , Yang WI , Kim CW , Huh J , Lee S-S , Cho EY , Ko Y-H , Charney D . Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: Significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma. Hum Pathol 32:954-962 2001

11.

Harris NL , Jaffe ES , Diebold J , Flandrin G , Muller-Hermelink HK , Vardiman J , Lister TA , Bloomfield CD . The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Histopathology 36:69-87 2000

12.

Coiffer B , Haioun N , Kettereer N , Engert A , Tilly H , Ma D , Johnson P , Lister A , Feuring-Buske M , Radford JA , Capdeville R , Diehl V , Reyes F . Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study. Blood 92:1927-1932 1998

13.

Pileri SA , Dirnhofer S , Went Ph , Ascani S , Sabattini E , Marafioti T , Tzankov A , Leoncini L , Falini B , Zinzani PL . Diffuse large B-cell lymphoma: One or more entities? Present controversies and possible tools for its subclassification. Histopathology 41:482-509 2002

14.

Allzadeh AA , Elsen MB , Davis RE , Ma C , Lossos IS , Rosenwald A , Boldrick JC , Sabet H , Tran T , Yu X , Powell JI , Yang L , Marti GE , Moore T , Hudson J Jr , Lu L , Lewis DB , Tlbshfrani R , Sherlock G , Chan WC , Greiner TC , Weisenberger DD , Armitage JO , Warnke R , Levy R , Wilson W , Grever MR , Byrd JC , Botstein D , Brown PO , Staudt LM . Distinct type of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511 2000

15.

Wang T , Lasota J , Hanau CA , Miettinen M . Bcl-2 oncoprotein is widespread in lymphoid tissue and lymphoma but its different expression in benign versus malignant follicles and monocytoid B-cell proliferation is of diagnostic value. APMIS 103:655-662 1995

16.

Lai R , Arber DA , Chang KL , Wilson CS , Weiss LM . Frequency of bcl-2 expression in nonHodgkin’s lymphoma: A study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 11:864-869 1998

Antigen Preservation in Infarcted Nodal B-Cell Lymphoma,with Special Reference to Follicular Center Cell Markers

Abstract

Keywords

Get full access to this article

References